SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization (full – 2004)http://jpet.aspetjournals.org/content/310/3/905.long
Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats (full – 2005) http://alcalc.oxfordjournals.org/content/40/1/46.long
SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats (abst – 2006)http://www.ncbi.nlm.nih.gov/pubmed/17127132
Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/17720206
Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22219220
Surinabant, a selective CB(1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703229/
Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats (full – 2005) http://alcalc.oxfordjournals.org/content/40/1/46.long
SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats (abst – 2006)http://www.ncbi.nlm.nih.gov/pubmed/17127132
Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/17720206
Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22219220
Surinabant, a selective CB(1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans (full – 2013)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703229/